Outcome of Moderate Severity in OPC Poisoning Patients When Treated With Pralidoxime
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
This open level randomized controlled trial will be conducted in the department of medicine
at Sir Salimullah Medical College and Mitford Hospital. Clinical severity will be assessed by
the POP (Peradeniya Organophosphorus Poisoning) scale of admitted patients having a history
of organophosphorus poisoning within 24 hours with clinical features and physical evidence of
poisoning consumed. Only moderate severity (POP Scale score 4-7) of OPC (Organophosphorus
compound) patients will be included in this study. Then one group of patients will be treated
with atropine and pralidoxime and another group will be treated with atropine. The outcome
will be noted as clinical improvement or recovery. hospital stay, requirement of ICU, death.